Screening Prognosis-Related lncRNAs Based on WGCNA to Establish a New Risk Score for Predicting Prognosis in Patients with Hepatocellular Carcinoma

被引:7
作者
Zhou, Xueliang [1 ]
Dou, Mengmeng [2 ]
Liu, Zaoqu [1 ]
Jiao, Dechao [1 ]
Li, Zhaonan [1 ]
Chen, Jianjian [1 ]
Li, Jing [1 ]
Yao, Yuan [1 ]
Li, Lifeng [3 ]
Li, Yahua [1 ]
Han, Xinwei [1 ]
机构
[1] Zhengzhou Univ, Dept Intervent Radiol, Affiliated Hosp 1, Zhengzhou, Peoples R China
[2] Zhengzhou Univ, Dept Neurol, Affiliated Hosp 1, Zhengzhou, Peoples R China
[3] Zhengzhou Univ, Dept Oncol, Affiliated Hosp 1, Zhengzhou, Peoples R China
关键词
LONG NONCODING RNA; CANCER; MICRORNAS; IDENTIFICATION; PROLIFERATION; METASTASIS; BIOMARKERS; APOPTOSIS; DIAGNOSIS; PATHWAYS;
D O I
10.1155/2021/5518908
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background. Hepatocellular carcinoma (HCC) remains an important cause of cancer death. The molecular mechanism of hepatocarcinogenesis and prognostic factors of HCC have not been completely uncovered. Methods. In this study, we screened out differentially expressed lncRNAs (DE lncRNAs), miRNAs (DE miRNAs), and mRNAs (DE mRNAs) by comparing the gene expression of HCC and normal tissue in The Cancer Genome Atlas (TCGA) database. DE mRNAs were used to perform Gene Ontology (GO), Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analysis. Then, the miRNA and lncRNA/mRNA modules that were most closely related to the survival time of patients with HCC were screened to construct a competitive endogenous RNA (ceRNA) network by weighted gene coexpression network analysis (WGCNA). Moreover, univariable Cox regression and Kaplan-Meier curve analyses of DE lncRNAs and DE mRNAs were conducted. Finally, the lasso-penalized Cox regression analysis and nomogram model were used to establish a new risk scoring system and predict the prognosis of patients with liver cancer. The expression of survival-related DE lncRNAs was verified by qRT-PCR. Results. A total of 1896 DEmRNAs, 330 DElncRNAs, and 76 DEmiRNAs were identified in HCC and normal tissue samples. Then, the turquoise miRNA and turquoise lncRNA/mRNA modules that were most closely related to the survival time of patients with HCC were screened to construct a ceRNA network by WGCNA. In this ceRNA network, there were 566 lncRNA-miRNA-mRNA regulatory pairs, including 30 upregulated lncRNAs, 16 downregulated miRNAs, and 75 upregulated mRNAs. Moreover, we screened out 19 lncRNAs and 14 hub mRNAs related to prognosis from this ceRNA network by univariable Cox regression and Kaplan-Meier curve analyses. Finally, a new risk scoring system was established by selecting the optimal risk lncRNAs from the 19 prognosis-related lncRNAs through lasso-penalized Cox regression analysis. In addition, we established a nomogram model consisting of independent prognostic factors to predict the survival rate of HCC patients. Finally, the correlation between the risk score and immune cell infiltration and gene set enrichment analysis were determined. Conclusions. In conclusion, the results may provide potential biomarkers or therapeutic targets for HCC and the establishment of the new risk scoring system and nomogram model provides the new perspective for predicting the prognosis of HCC.
引用
收藏
页数:20
相关论文
共 50 条
  • [21] A New Risk Score Based on Eight Hepatocellular Carcinoma- Immune Gene Expression Can Predict the Prognosis of the Patients
    Ye, Dingde
    Liu, Yaping
    Li, Guoqiang
    Sun, Beicheng
    Peng, Jin
    Xu, Qingxiang
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [22] Identification of Epithelial Mesenchymal Transition-Related lncRNAs Associated with Prognosis and Tumor Immune Microenvironment of Hepatocellular Carcinoma
    Zhou, Yongjie
    Wang, Liangwen
    Zhang, Wen
    Ma, Jingqin
    Zhang, Zihan
    Yang, Minjie
    Yu, Jiaze
    Luo, Jianjun
    Yan, Zhiping
    DISEASE MARKERS, 2022, 2022
  • [23] Cuproptosis-related lncRNAs predict the prognosis and immune response in hepatocellular carcinoma
    Qiongyue Zhang
    Yan Huang
    Yu Xia
    Yumeng Liu
    Jianhe Gan
    Clinical and Experimental Medicine, 2023, 23 : 2051 - 2064
  • [24] Random-forest algorithm based biomarkers in predicting prognosis in the patients with hepatocellular carcinoma
    Guo, Lingyun
    Wang, Zhenjiang
    Du, Yuanyuan
    Mao, Jie
    Zhang, Junqiang
    Yu, Zeyuan
    Guo, Jiwu
    Zhao, Jun
    Zhou, Huinian
    Wang, Haitao
    Gu, Yanmei
    Li, Yumin
    CANCER CELL INTERNATIONAL, 2020, 20 (01)
  • [25] Construction and validation of a necroptosis-related lncRNAs prognosis signature of hepatocellular carcinoma
    Peng, YunZhen
    Wu, GuoJing
    Qiu, Xin
    Luo, Yue
    Zou, YiShu
    Wei, XueYan
    Li, Aimin
    FRONTIERS IN GENETICS, 2022, 13
  • [26] Cuproptosis- and m6A-Related lncRNAs for Prognosis of Hepatocellular Carcinoma
    Zhu, Yuezhi
    Tan, Jen Kit
    Goon, Jo Aan
    BIOLOGY-BASEL, 2023, 12 (08):
  • [27] A GenomicInstability-Related LongNoncodingRNASignature for Predicting Hepatocellular Carcinoma Prognosis
    Lu, Jing
    Cao, Wanyue
    He, Zeping
    Wang, Haoyu
    Hao, Jialing
    Xu, Junming
    JOURNAL OF ONCOLOGY, 2022, 2022
  • [28] Development and Validation of a Pyroptosis-Related Signature for Predicting Prognosis in Hepatocellular Carcinoma
    Ding, Jianfeng
    He, Xiaobo
    Luo, Wei
    Zhou, Weiguo
    Chen, Rui
    Cao, Guodong
    Chen, Bo
    Xiong, Maoming
    FRONTIERS IN GENETICS, 2022, 13
  • [29] Screening of Prognosis-Related Genes in Primary Breast Carcinoma Using Genomic Expression Data
    Gu, Yifan
    Chen, Guoqing
    Du, Yibao
    JOURNAL OF COMPUTATIONAL BIOLOGY, 2020, 27 (07) : 1030 - 1040
  • [30] Identification of a glycolysis-related gene signature for predicting prognosis in patients with hepatocellular carcinoma
    Kong, Junjie
    Yu, Guangsheng
    Si, Wei
    Li, Guangbing
    Chai, Jiawei
    Liu, Yong
    Liu, Jun
    BMC CANCER, 2022, 22 (01)